IPO - Profile

Summary

We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world’s largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$18.00 24,240,000 Positive High 23.46%

Offering Team

  • Legal counsel
  • Davis Polk & Wardwell LLP
  • Auditors
  • Ernst & Young LLP

Deal Highlights

Deal Tracker

IPO Dates

Filing 15 Apr, 2021

Offer 16 Apr, 2021

Look Ahead

Lock Up Expiry Oct 16, 2021

IPO Terms

Offer Price $18.00
Offer Size 24M

Market Sentiments

Stock Price